GLP-1 medications like Ozempic, Wegovy, and Zepbound have become some of the most talked-about treatments for weight loss, but their benefits may extend far beyond the scale.

In this episode, Diana breaks down what GLP-1 medications are, how they work in the body, and what current research shows about kidney health. She explores the growing evidence for kidney protection, discusses emerging research in autosomal dominant polycystic kidney disease (ADPKD), and shares practical considerations for people with PKD who are considering semaglutide or tirzepatide medications.

SHOW NOTES, REFERENCES, & TRANSCRIPTS

• www.thepkddietitian.com/58
• Episode #57: Weight Loss & PKD: Can It Slow Kidney Growth and Disease Progression?
• GLP1 Clinical Trial: Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
• FLOW Trial: https://pubmed.ncbi.nlm.nih.gov/38785209/
• Support the Show: patreon.com/PKDDietitian

WORK WITH DIANA: thepkddietitian.com/workwithme

HAVE A QUESTION? Send a message to info@thepkddietitian.com

FIND THE PKD DIETITIAN ONLINE

• Patreon: PKDDietitian
• Instagram: @The.PKD.Dietitian
• Facebook: The PKD Dietitian
• Website: thepkddietitian.com

Support the show and access future bonus content and deeper PKD nutrition insights: patereon.com/PKDDietitian

DISCLAIMER

The PKD Dietitian Podcast is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.